Vor Biopharma Inc. (VOR) Balance Sheet
As of 2026-06-30 (10-Q), Vor Biopharma Inc. (VOR) reported total assets of $481.1M, total liabilities of $681.3M and shareholders' equity of -$200.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $107.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VORVor Biopharma Inc.Follow VOR — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 119.8 | 57.7 | 31.4 | 81.9 | 396.5 | 107.9 | |
| Short-term investments | 87.7 | 172.5 | 105.8 | 10.0 | 58.7 | 358.3 | |
| Current assets | 214.4 | 237.0 | 140.8 | 96.5 | 458.1 | 475.1 | |
| Total assets | 242.6 | 299.4 | 198.1 | 142.9 | 464.1 | 481.1 | |
| Current liabilities | 10.2 | 13.1 | 15.6 | 18.6 | 25.2 | 24.8 | |
| Total liabilities | 26.3 | 48.8 | 47.4 | 46.2 | 628.4 | 681.3 | |
| Shareholders' equity | 216.3 | 250.6 | 150.7 | 96.7 | -164.3 | -200.2 |
USD millions · SEC XBRL
Vor Biopharma Inc. — questions
- How much cash does Vor Biopharma Inc. have?
- $107.9M in cash and cash equivalents as of 2026-06-30.
- What are Vor Biopharma Inc.'s total assets?
- $481.1M as of 2026-06-30.
- What is Vor Biopharma Inc.'s shareholders' equity?
- -$200.2M as of 2026-06-30.
Every figure on this page comes from Vor Biopharma Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.